Skip to content
Contactez-nous: (+33) 1 64 62 10 12
Theradiag
  • Home
  • Company
    • About us
    • Our history
    • Our management team
    • Know-how
    • Privacy policy
  • Theranostic
    • Therapeutic Drug Monitoring of Biologics
      • When to perform TDM ?
      • Results interpretation
      • Therapeutic Thresholds
      • Tracker Publications
      • Guidelines
      • Frequently asked questions
    • TRACKER
      • LISA TRACKER
      • i-Tracker
      • i-Track 10
      • ez-Track1 & ez-Tracker
      • Immunotrol Tracker
  • Diagnostics
    • Autoimmunity
      • Reagents – Autoimmunity
      • Quality Control – Auto-Immunity
    • Other fields
    • Instrumentation
      • Theralis
      • FIDIS™
  • Services
    • Technical Documentation Download Center
  • News
    • Press Releases
    • List of upcoming events
    • Congress calendar
  • Contacts
  • Français
  • English
Menu Close

Author: mtraore

This author has written 149 articles
  1. Home>
  2. mtraore>
  3. Page 10

12/05/2017 : Successful capital increase, raising €4 million

  • Post author:mtraore
  • Post published:12 May 2017
  • Post category:Press Releases

Croissy-Beaubourg and Montpellier, May 12, 2017 – 8:00am CET – THERADIAG (ISIN: FR0004197747, ticker: ALTER, eligible for PEA-PME equity savings plans in France), a company specializing in in vitro diagnostics and theranostics, has successfully completed…

Continue Reading12/05/2017 : Successful capital increase, raising €4 million

11/05/2017 : Theradiag announces the launch of a capital increase

  • Post author:mtraore
  • Post published:11 May 2017
  • Post category:Press Releases

Croissy-Beaubourg and Montpellier, May 11, 2017 – 6:15pm CET – THERADIAG (ISIN: FR0004197747, ticker: ALTER, eligible for PEA-PME equity savings plans in France), a company specializing in in vitro diagnostics and theranostics, is today announcing…

Continue Reading11/05/2017 : Theradiag announces the launch of a capital increase

27/04/2017 : First-quarter 2017 revenues

  • Post author:mtraore
  • Post published:27 April 2017
  • Post category:Press Releases

Revenue growth of 5%Continuous strong growth in theranostics sales: +27%Theranostics revenues up to 50% of total salesCroissy-Beaubourg and Montpellier, April 27, 2017, 8:00am CEST – THERADIAG (ISIN: FR0004197747, Ticker: ALTER, eligible for PEA-PME plans), a company…

Continue Reading27/04/2017 : First-quarter 2017 revenues
  • Go to the previous page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 24
  • Go to the next page

Latest Press Releases

  • 15/12/2023: COMPLETION OF THE THERADIAG MERGER-ABSORPTION BY BIOSYNEX
    15 December 2023/
    0 Comments
  • 11/10/2023: Theradiag reports 20% revenue growth in Q3 2023
    11 October 2023/
    0 Comments
  • 18/09/2023: Theradiag announces its 2023 half-year results and reports a significant improvement in profitability
    18 September 2023/
    0 Comments

Events

No event found!

Next financial Event

No event found!

Useful links

  • Diagnostic
  • Theranostic
  • Events
  • Register to receive our latests news

Contact Information

  • Address:14, Rue Ambroise Croizat, 77183 Croissy Beaubourg, France
  • Phone:+33 1 64 62 10 12
  • Email:info.croissy@biosynex.comOpens in your application

Follow Us

Biosynex - Theradiag ©
  • Home
  • Company
    • About us
    • Our history
    • Our management team
    • Know-how
    • Privacy policy
  • Theranostic
    • Therapeutic Drug Monitoring of Biologics
      • When to perform TDM ?
      • Results interpretation
      • Therapeutic Thresholds
      • Tracker Publications
      • Guidelines
      • Frequently asked questions
    • TRACKER
      • LISA TRACKER
      • i-Tracker
      • i-Track 10
      • ez-Track1 & ez-Tracker
      • Immunotrol Tracker
  • Diagnostics
    • Autoimmunity
      • Reagents – Autoimmunity
      • Quality Control – Auto-Immunity
    • Other fields
    • Instrumentation
      • Theralis
      • FIDIS™
  • Services
    • Technical Documentation Download Center
  • News
    • Press Releases
    • List of upcoming events
    • Congress calendar
  • Contacts
  • Français
  • English